Home > Browse Research > Life Sciences > Biotechnology > Proteomics

Proteomics: market research reports

Proteomics market research reports and industry analysis

Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2011 2/1/2011 \| published by: BioSeeker Group AB ... line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, there is plenty of room for more competition. There are ... \| read more...	$2,249.00
The 2011-2016 World Outlook for Proteomic Protein Chips 1/20/2011 \| published by: Icon Group International, Inc. ... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... \| read more...	$795.00
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine 1/1/2011 \| published by: JZMed, Inc. ... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ... \| read more...	$3,285.00
Growth Factors ( Blood And Tissue ) 1/1/2011 \| published by: Global Industry Analysts ... The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these ... \| read more...	$4,500.00
Biotechnology Reagents 1/1/2011 \| published by: Global Industry Analysts ... Reaction Reagents, and Protein Synthesis Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, ... \| read more...	$4,500.00
Advances in Mass Spectrometry (Technical Insights) 12/30/2010 \| published by: Frost & Sullivan This research service outlines the key developments taking place globally and emerging trends in the field of mass spectrometry techniques and application landscape analysis. \| read more...	$6,500.00
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 12/1/2010 \| published by: GBI Research ... and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics ... \| read more...	$3,500.00
Therapeutic Proteins to 2014 11/15/2010 \| published by: Greystone Research Associates ... becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively ... \| read more...	$4,850.00
Top 10 Drug Discovery Technologies - Strategic Analysis And Global Forecasts 11/1/2010 \| published by: MarketsandMarkets ... the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies. The applications of these technologies in the introduction of drugs for diverse diseases ... \| read more...	$4,650.00
Cancer Profiling and Pathways: Technologies and Global Markets 9/1/2010 \| published by: BCC Research ... rate (CAGR) of 21.6% over the next 5 years. Proteomics were worth $7.9 billion in 2009. This segment is expected to increase to $9.4 billion in 2010 and reach $19.5 billion by 2015, at a ... \| read more...	$5,450.00
Biomarkers: Applications and Trends 8/3/2010 \| published by: Espicom Healthcare Intelligence ... development, the number of new NCE and biological products reaching the market has not improved. A new way of conducting research has to be found and much hope and investment is being set by Biomarkers. \| read more...	$1,215.00
Protein Drugs 8/1/2010 \| published by: Global Industry Analysts ... forecasts are provided for the period 2006 through 2015. The report profiles 56 companies including many key and niche players such as Abbott Laboratories, Inc., Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec, Bristol-Myers Squibb Company, ... \| read more...	$3,950.00
Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects 8/1/2010 \| published by: PharmaVision ... & leading technologies driving the field; evaluate the unmet clinical needs, product pipelines & technological challenges for the next generation of mAbs & TPs; identify the key regulatory, IP & reimbursement issues which face biopharmaceutical ... \| read more...	$1,566.00
Therapeutic Protein Production: A Changing Landscape 7/1/2010 \| published by: CHI Insight Pharma Reports ... disposables throughout the process and the shift to animal extracts-free culture media are three of the major themes covered by this report. The impact of global competition, lower barriers to entry and the shift in ... \| read more...	$3,750.00
Mastering Biomarkers: Five Top Diagnostics Companies to Watch 6/28/2010 \| published by: Decision Resources ... embracing strategies that have enabled them to win on all three fronts. These companies are at the core of industry growth because of their unparalleled strategic decision making, product offerings, market and product diversifi cation, ... \| read more...	$4,600.00
Conference Documentation: Global Proteins Summit (2010) 6/23/2010 \| published by: SMI Publishing, Ltd ... latest developments in protein therapeutics, cell culture expression and immunogenicity. The conference will explore the next generation of protein therapeutics, how they are being developed and reassess the technology, discovery and delivery trends. Also covered ... \| read more...	$998.00
Bioinformatics in Drug Discovery (Technical Insights) 6/5/2010 \| published by: Frost & Sullivan This research service discusses the role of bioinformatics in drug discovery with a specific focus on in silico applications. \| read more...	$6,500.00
Innovations in Combating Infectious Diseases: Opportunities in therapeutics and diagnostics through application of proteomics, genomics, nanotechnology, and novel sources of lead generation 6/1/2010 \| published by: Business Insights ... many infectious diseases has not been accomplished. Of particular current concern are the problems of rapidly developing drug resistance, emerging disease, re-emerging disease, the threat of bioterrorism, and the speed of reaction to the appearance ... \| read more...	$3,835.00
The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 4/1/2010 \| published by: Business Insights ... 30% of all currently marketed drugs acting on one or more GPCRs. Despite this, there are many GPCRs that have yet to be effectively exploited, for a variety of reasons. A number of new approaches ... \| read more...	$3,835.00
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics 3/1/2010 \| published by: BCC Research ... with trends and forecasts for growth through 2014 Offers a focus on particular applications of epigenomics, including research tools, diagnostics, drugs and cloning/tissue engineering Discusses industry structure including, mergers and acquisitions, distribution of products, government ... \| read more...	$5,450.00
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook 3/1/2010 \| published by: Business Insights ... as people and healthcare institutes are skeptical of investing in technologies that have not provided very wide and acceptable results. The impact of cost constraints will diminish as the cost/value benefit is established. The future ... \| read more...	$3,835.00
Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast 2/14/2010 \| published by: Renub Research ... from past trends to future scenario (2006 to 2015). Personalized medicine segments like Genetically Modified (GM) Products, Wellness & Disease Management, Targeted Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data ... \| read more...	$1,100.00
Biomarkers, Tests and Trends for Drug R&D 2/1/2010 \| published by: Takeda Pacific ... tools & technologies, products and R&D services. This report provides a detailed outlook of the market for biomarkers and related genomic, proteomic, or other tests used in drug R&D programs. The research report also touches ... \| read more...	$2,195.00
Single Cell Analysis 2010: the New Frontier for 'Omics Market Report 1/1/2010 \| published by: Select Biosciences Limited ... large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. ’Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in ... \| read more...	$4,120.00
The 2011 Global Animal Health Market Dynamics and Trends 1/1/2010 \| published by: Venture Planning Group ... on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue ... \| read more...	$1,750.00

< prev 1 2 3 4 5 6 7 next >